Brief: Larimar Therapeutics announces regulatory update call on Nomlabofusp Program
June 20 (Reuters) - Larimar Therapeutics Inc LRMR.O: LARIMAR THERAPEUTICS ANNOUNCES REGULATORY UPDATE CALL ON THE NOMLABOFUSP PROGRAM FOR THE TREATMENT OF FRIEDREICH’S ATAXIA Source text: ID:nGNX6N6lcJ Further company coverage: LRMR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Larimar Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
Larimar tumbles as safety concerns resurface in rare disease drug study update
U.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
U.S. STOCKS ON THE MOVE-SpaceX, Charter, Gulfport Energy
Larimar tumbles as safety concerns resurface in rare disease drug study update